WHO ARE WE - OUR KEY DIFFERENTIATORS

STATE OF THE ART cGMP FACILITY

solution provider

Skyepharma invests in state-of-the-art equipment in laboratories capabilities

12 avril 2018 – Skyepharma’s Analytical Development department recently acquired a BET Analyzer, used for Surface area and Pore...
Read More

SKYEPHARMA improves time to market

28 février 2018 –   David LESCUYER – EVP Oral Business, Vectura Group of Companies – President...
Read More

SKYEPHARMA ACQUIRES A NEW MARCHESINI BOTTLING LINE

7 février 2018 –   4.1 million Investment results in upgrade to SKYEPHARMA Development & Manufacturing site...
Read More
LOOKING FOR A CDMO PARTNER ?
Our unique selling point is to be a solution provider ensuring customer satisfaction.